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Abstract
A microfluidic system consisting of generic single use cartridges which interface
with a workstation allows the automatic performance of all necessary sample
preparation, PCR analysis and interpretation of multiplex PCR assays. The
cartridges contain a DNA array with 20 different 16mer DNA “universal” probes
immobilized at defined locations. PCR amplicons can be detected via hybridization
of user-defined “reporter” probes that are complementary at their 3′ termini to one
or more of the universal probes and complementary to the target amplicons at their
5′ termini. The system was able to detect single-plex and multiplex PCR amplicons
from various infectious agents as well as wild type and mutant alleles of single
nucleotide polymorphisms. The system's ease of use was further demonstrated by
converting a published PCR assay for the detection of Mycobacterium genitalium
in a fully automated manner. Excellent correlation between traditional manual
methods and the automated analysis performed by the workstation suggests that the
system can provide a means to easily design and implement a variety of
customized PCR-based assays. The system will be useful to researchers or clinical
investigators seeking to develop their own user defined assays. As the U.S. FDA
continues to pursue regulatory oversight of LDTs, the system would also allow labs
to continue to develop compliant assays.
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1. Introduction
The ability to amplify and detect specific nucleic acids by polymerase chain
reaction (PCR) or other gene amplification methods has greatly expanded the scope
and use of nucleic acid assays into a variety of diverse fields. Molecular
diagnostics has become a valuable tool in healthcare by providing a means to
identify infectious agents [1], characterize malignant tumors [2], predict sensitivity
to pharmacologic agents [3], and stratify oncology patients into responders and
non-responders [4], thus allowing physicians to make well-informed decisions
about medical treatment. Bioinformatics information gleaned from the human
genome project can also provide valuable information about possible health risk
factors [5]. In addition to clinical applications, nucleic acid assays have also
expanded to fields such as food and beverage testing [6, 7], forensics [8, 9], and
quality control in personal care products production [10]. In general, each of these
applications relies upon gene amplification technology, often PCR, to first increase
the total number of targets to detectable levels and then either simultaneously
detect those molecular targets via “real time” fluorescence methods or at the
completion of the amplification process by “end point” analysis of the resulting
amplicons using DNA arrays. Both approaches have distinct advantages. Real time
methods provide an effective means to quantitate the concentration of the target
sequences. One example of the clinical utility of real time methods is the
monitoring of HIV viral loads, thus providing a means to monitor the efficacy of
therapeutic interventions in the treatment of HIV infection [11]. In the food and
beverage industry, real time methods also provide a means to quantitate the level of
pathogen contamination [12] in materials intended for human consumption.
Despite the power of such real time methods, however, one drawback is the limited
number of targets that can be simultaneously detected. Since quantitation relies
upon the ability to detect and distinguish the emission of fluorescent dyes bound to
probe molecules, it is necessary to use fluorescent dyes that have non-overlapping
emission spectra in order to achieve multiplex detection of multiple targets in a
single reaction. The total number of targets detected in a fluorescence-based
multiplex PCR is often in the range of 4–6 [13]. A variety of novel methods have
been developed, however, that can increase the number of detectable targets in real
time assays. The use of melting profiles has been used to distinguish multiple
amplicons generated in a single PCR using the same detection dye [14]. Other
methods, including Target Enriched Multiplex (TEM) PCR can be used to further
enrich the target population and allow detection of up to 20 individual targets
within the same sample [15, 16]. Finally, Multiple Detection Temperature (MuDT)
technology has also been used to detect multiple targets in a single reaction using a
single dye [17]. In contrast to real time methods, detection of multiple targets in
“end point” detection methods provides a simple means to detect a large number of
individual targets. Since detection does not rely upon fluorescence, there is no need
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to utilize expensive optical equipment or strive to deconvolute overlapping
emission spectra. But, in order to achieve effective end point detection, specific
probes complementary to the target sequences need to be immobilized on either a
fixed substrate such as a DNA array [18, 19] or onto magnetic beads [20, 21].
Regardless of the specific method used, it is necessary for the user to design and
immobilize the probes to a suitable substrate before the assay is performed. From a
commercial standpoint, this represents a disadvantage since a manufacturer seeking
to provide a broad spectrum of assay kits or products would require knowledge of
the user's specific targets of interest in order for the correct probes to be provided
on the arrays. Furthermore, manufacturers of fully integrated systems that can
automatically process a raw specimen through lysis, purification, amplification and
detection are at a further disadvantage since the power of such fully integrated
systems is diminished because a multitude of different probe sets would be
required for the systems to be suitable for widespread commercial use. While
xMAP technology provides a means for investigators to functionalize microspheres
for detection of multiple targets [22], our goal was to provide a simplified means to
not only functionalize the DNA array, but to also include a seamless, fully
integrated analysis of the user's specimens. Such a system becomes especially
useful in research laboratories that need to develop assays “on the fly” for their
particular use. Moreover, in clinical settings where laboratories, regulated by the
Clinical Laboratory Improvement Amendment (CLIA) develop their own
laboratory developed tests (LDTs), such labs would have to rely on such
commercial entities to provide specific probes within their systems in order to
detect the user's targets of interest.
The U.S. Food and Drug Administration (FDA) has recently released draft
guidance documents indicating that enforcement discretion of user defined assays
is likely to end, at least for Class II and Class III medical devices, and reiterated its
position that a “traditional LDT” is defined as a test that was developed and used
within a single laboratory without assistance from outside parties [23, 24].
Although there has been considerable opposition to the new draft guidance
documents by CLIA laboratories and multiple laboratory associations, it is
apparent that changes to oversight of LDTs, either by the FDA, the Centers of
Medicare and Medicaid Services (CMS) or both is likely to occur in the future. In
order to overcome the limitations of current commercial systems and to provide
universal “plug and play” functionality, we set out to expand the capabilities of our
current fully automated system [25, 26, 27] to allow end users to automatically
functionalize DNA arrays contained within generic microfluidic cartridges
interfaced with a programmable workstation. Another goal of this effort was to
allow the system to achieve the required functionalization of the universal array
while the rest of the assay was underway, thus eliminating any delay in having the
DNA arrays functionalized and available for hybridization. Such a system will
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provide considerable versatility to users in multiple fields, allowing laboratories in
various clinical and nonclinical settings to design customized and fully automated
assays as needed. In addition, such a system will also allow CLIA labs to remain
compliant to the anticipated changes in LDT regulations, since the laboratories will
not have to rely upon a manufacturer to prepare specific DNA arrays.
2. Materials and methods
2.1. Generic cartridges
The cartridge used in the present studies is an injection molded homopolymeric
polystyrene structure (Fig. 1) similar to that previously described [25]. It contains
all of the pumps, valves, microchannels, reaction and reagent reservoirs, and the
integrated universal DNA array necessary to perform fully automated assays. Each
of the cartridges can perform sample lysis, purification, amplification and
hybridization steps simultaneously on four separate samples. When inserted into
the workstation, the workstation's software controls all of the assay steps on up to a
total of six cartridges in parallel, thus allowing the simultaneous analysis of up to
24 separate samples.
2.2. Universal probe design and synthesis
The twenty probes immobilized on the substrate were designed according to the
methods previously described by Gerry et al. [28] with the exception that only four
tetramers, instead of six, were used to design 16mer oligonucleotide probes. The 5′
aminoterminated probes were obtained from Integrated DNA Technologies
[(Fig._1)TD$FIG]
Fig. 1. (Left) A schematic of the Rheonix CARD® cartridge depicting the four identical lanes used to
automatically analyze four independent specimens. Within each lane, cells are lysed, DNA extracted,
purified, and the resulting DNA subjected to PCR. The amplicons generated in the PCR reaction
chambers are subsequently detected on the four separate DNA microarrays (MAR) shown. The various
microchannels, diaphragm pumps and valves have been previously described in detail [25]. (Right) A
side view of the cartridge showing the underside microchannel layer and suspended PCR tubes.
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(Coralville, IA) and the lyophilized oligonucleotides were then re-suspended in 0.5
M NaHCO3 at a concentration of 200 μM for covalent linkage to activated Biodyne
membranes obtained from Pall Corporation (Port Washington, NY) via 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimde (EDAC) chemistry [29].
2.3. Generic cartridge and universal DNA microarrays
To achieve detection of specific PCR amplicons, two different types of probes
were utilized (Fig. 2). One set of 16mer probes, independent of the amplicon
sequences being detected, served as “universal” probes, and were immobilized on
the surface of the DNA microarray (Table 1). A second set of “reporter” probes
were designed with 34–45 nucleotides of their 3′ termini complementary to the 3′
portion of particular immobilized universal probes (Table 1) and 18–25 nucleotides
at their 5′ termini complementary to the 3′ end of individual target amplicon
sequences. To investigate this approach, the universal microarray filters were
spotted with the universal probes (Table 1) at concentrations of 2 μM, 20 μM, or
both concentrations, in spotting buffer containing 0.25 M NaHCO3, 25%
polyethylene glycol (MW 8000), 0.1% Tween 20 and 150 μM Rhodamine-B.
[(Fig._2)TD$FIG]
Fig. 2. A schematic representation of a particular immobilized probe adhered at its modified 5’end to
the filter substrate. A reporter probe is shown hybridized at its 3′ end to the immobilized probe and
hybridized to the target amplicon at its 5′ end.
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Once in solution, the universal probes were applied to the activated Biodyne
membranes that were fixed on a plastic support.
2.4. Samples used to isolate DNA
To demonstrate the versatility of the system, DNA was isolated from a variety of
samples exactly as previously described [25, 26]. Detection of the infectious
agents, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis
Table 1. Nucleotide sequences of 20 different universal probes immobilized on
the cartridge's integrated DNA array. All sequences are modified at their 5′
termini to facilitate binding to the activated membrane as described in Materials
and Methods. The reporter probes were designed to be complementary, at their
respective 3’termini, to the universal probes immobilized on the DNA array. As
described in Materials and Methods, the reporter probes were further modified at
their 5′ termini to include sequences complementary to the target amplicons (see
also Fig. 2).
Probe ID Number Nucleotide sequence (5′ → 3′)
Universal Probes Complementary Reporter Probes
1 /5AmMC6/TGCGACCTCAGCATCG CGATGCTGAGGTCGCA
2 /5AmMC6/CAGCACCTGACCATCG CGATGGTCAGGTGCTG
3 /5AmMC6/GACCACCTTGCGATCG CGATCGCAAGGTGGTC
4 /5AmMC6/TGCGGGTACAGCACCT AGGTGCTGTACCCGCA
5 /5AmMC6/CAGCGGTAGACCACCT AGGTGGTCTACCGCTG
6 /5AmMC6/GACCGGTATGCGACCT AGGTCGCATACCGGTC
7 /5AmMC6/TGCGATCGCAGCGGTA TACCGCTGCGATCGCA
8 /5AmMC6/CAGCATCGGACCGGTA TACCGGTCCGATGCTG
9 /5AmMC6/GACCATCGTGCGGGTA TACCCGCACGATGGTC
10 /5AmMC6/AGCCCTTGCACGTCTG CAGACGTGCAAGGGCT
11 /5AmMC6/CACGCTTGGTGCTCTG CAGAGCACCAAGCGTG
12 /5AmMC6/GTGCCTTGAGCCTCTG CAGAGGCTCAAGGCAC
13 /5AmMC6/AGCCGATGCACGCTTG CAAGCGTGCATCGGCT
14 /5AmMC6/CACGGATGGTGCCTTG CAAGGCACCATCCGTG
15 /5AmMC6/GTGCGATGAGCCCTTG CAAGGGCTCATCGCAC
16 /5AmMC6/AGCCTCTGCACGGATG CATCCGTGCAGAGGCT
17 /5AmMC6/CACGTCTGGTGCGATG CATCGCACCAGACGTG
18 /5AmMC6/TCCCCTGTGGACTGTC GACAGTCCACAGGGGA
19 /5AmMC6/ACGGCTGTTCCCTGTC GACAGGGAACAGCCGT
20 /5AmMC6/GGACTGTCACGGAGTG CACTCCGTGACAGTCC
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was demonstrated by spiking the organisms into phosphate buffered saline either
individually or combined prior processing on the CARD cartridge. The detection of
single nucleotide polymorphisms (SNPs) was demonstrated by analyzing buccal
swabs collected from volunteers after IRB-approved informed consent forms were
signed. The buccal swab samples were obtained using FLOQSwabsTM purchased
from Copan Diagnostics, Inc. (Murrieta, CA) and suspended in phosphate buffered
saline. DNA was then automatically isolated on the CARD cartridge from the
samples and PCR amplified exactly as previously described [25, 26]. Finally, in
order to demonstrate a higher multiplex detection of multiple targets, 5′
biotinylated DNA sequences, corresponding to multiple human papilloma virus
(HPV) subtypes and other sexually transmitted infection (STI) agents were
purchased from Integrated DNA Technologies and served as surrogate amplicons.
2.5. PCR amplification
The PCR amplification of individual sequences was first optimized for the
particular target(s) of interest using standard bench top methods. Once optimized,
the workstation was programmed to automatically perform each of the individual
sample preparation, PCR and detection steps for the various assays. Since the assay
conditions varied, particularly the levels of stringency required to detect SNPs
versus the STI targets, the PCR amplification and detection conditions were
separately optimized and then programmed into the workstation to conduct the
fully automated assays.
The STI targets were amplified in a PCR master mix formulated for multiple
targets containing 10 mM Tris-HCl pH 9.00, 50 mM KCl, 2.5 mM MgCl2, 400 μM
dNTPs, 0.5 μM forward and biotinylated reverse primers for C.trachomatis, N.
gonorrhoeae and T.vaginalis and 0.2 Units of Taq polymerase (Promega) in a final
volume of 15 μl. The specimens were denatured at 95 °C for 2 min, followed by 40
cycles of denaturation at 95 °C for 30 s, annealing and extension at 71 °C for 30 s.
The final extension was carried out for 3 min at 72 °C.
A previously published manual method [30] for detection of Mycoplasma
genitalium (MG) was also migrated to the cartridge. The PCR assay conditions
were exactly as previously described, with the exception that endpoint detection of
the amplicons replaced the real time PCR process. Three separate reporter probes
for the MG amplicon were designed that had identical sequences complementary to
the gap sequence [30] on their 5′ termini, while the 3′ termini of the reporter
probes were complementary to three different universal probes on the DNA array.
The PCR amplification of SNPs associated with warfarin sensitivity (Cyp2C9*2,
Cyp2C9*3 and VKORC1) was carried out in a final volume of 15 μl containing 1.5
mM MgCl2, 200 μM dNTPs, 0.4 μM forward and reverse primers. Since the
amplification of the CYP2C9 and VKORC1 targets required different master
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mixes, the cartridge design included two separate PCR chambers per lane.
Therefore one of the master mixes was automatically introduced into one of the
PCR chambers to amplify the CYP2C9 targets while the second master mix was
introduced into the second PCR chamber to amplify the VKORC1 target. At the
conclusion of the thermocycling, the amplicons from both PCR chambers were
automatically combined on the cartridge for further analysis on the integrated
universal DNA microarray. For both PCR reaction vessels, the thermal cycling
conditions included an initial denaturation at 95 °C for 2 min, followed by 40
cycles of denaturation at 95 °C for 30 s, annealing at 48 °C for 30 s, and extension
at 72 °C for 30 s. The final extension was carried out for an additional 5 min at 72
°C. For SNP PCR reactions, the primer pairs were biotinylated at both termini [26]
in order to facilitate detection via streptavidinylated horse radish peroxidase.
2.6. Two-step versus sequential microarray hybridization
The methods used to detect the specific amplicons on the universal array were
optimized according to the types of targets being analyzed. A two-step
hybridization process, whereby the “reporter” probe was first allowed to hybridize
to the immobilized “universal” probe and then the available reporter probe
sequences allowed to hybridize to the PCR amplicons was ideal for detection of
STI targets. On the other hand, a sequenced hybridization process was found to be
effective for SNP detection. To accomplish detection of SNPs, the “reporter”
probes designed to detect the wild type alleles were first allowed to hybridize to the
immobilized “universal” probes, followed by hybridization of the denatured PCR
amplicon mix to the reporter probes. Then, the “reporter” probes designed to detect
the mutant alleles were subsequently introduced to hybridize to their appropriate
“universal” probes, followed by hybridization of another aliquot of the same
denatured PCR amplicon mix to the second set of reporter probes. As described
below in more detail, although the sequence of events slightly differed in the two
different hybridization approaches, they could easily be programmed into the
workstation. In both cases, the ultimate detection of the various amplicons was
achieved by incubation with streptavidinylated horse radish peroxidase (HRP),
followed by 3, 3′,5, 5′-tetramethylbenzydine (TMB) for color development. The
signal generated by incubation of HRP with TMB was detected after six minutes
by allowing the workstation's onboard Cognex (Natick, MA) CMOS camera to
capture the images which were then processed by the instruments imaging software
[26].
2.7. Two-step hybridization
The integrated universal DNA microarray filters were first washed with 100 μl of
hybridization buffer (150 mM NaCl, 10 mM NaH2PO4, 1 mM EDTA and 0.1%
SDS) at 40 °C for 2 min after which the buffer was pumped out to the cartridge's
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waste reservoir. Fresh hybridization buffer (100 μl) was then pumped into the
microarray chambers and 5 μl of the appropriate reporter probe mix allowed to
flow over each of the microarrays. Hybridization was carried out at 40 °C for 10
min. While the first step of hybridization was underway 15 μl of amplicon was
diluted to 100 μl with hybridization buffer and denatured at 95 °C for 5 min. Then
70 μl of the denatured amplicon solution was pumped into the microarray chamber
along with 30 μl of hybridization buffer from the reagent reservoir. Hybridization
was allowed to proceed for 10 min at 40 °C. After pumping the sample out of the
microarray chamber, the filters were then washed with 100 μl of hybridization
buffer at 40 °C for 5 min and a second wash carried out at room temperature for 30
s. Following these washes, the filters were incubated with 100 μl of
streptavidinylated HRP for 5 min at room temperature followed by four washes
of 30 s each with hybridization buffer at room temperature. One hundred μl of
TMB was then dispensed and pumped into each of the microarray chambers and
incubated for 7 min at room temperature to generate the color reaction which was
stopped by washing 20% Ethanol through the microarray chamber. The filters were
finally imaged by the workstation's optics system in the 20% Ethanol solution.
2.8. Sequenced hybridization for SNPs
Buccal cells were collected from volunteers whose genotypes for CYP2C9*2,
CYP2C9*3 and VKORC-1 were determined by bidirectional Sanger Sequencing as
previously described [26]. The microarray filters were initially washed in
hybridization buffer for 2 min prior to reporter probe hybridization. The
hybridization buffer was then pumped out of the microarray chamber to the waste
reservoir and 100 μl of fresh hybridization buffer pumped into the microarray
chamber, followed by 5 μl of the wild type reporter probe mixture (0.125 μM of
Cyp2C9*2 and 0.5 μM of Cyp2C9*3 and VKORC-1) in Buffer A (300 mM NaCl,
20 mM NaH2PO4, 2 mM EDTA and 0.1% SDS). The reporter probe mixture was
then allowed to hybridize with the universal probes in the microarray chamber at
50 °C for 10 min. After the final extension of the PCR reaction, the entire volume
of the PCR amplicons (5 μl) was diluted in 100 μl of Buffer A and denatured at 95
°C for 5 min. Thirty μl of the diluted amplicons were then pumped into the
microarray chamber along with 70 μl of Buffer A simultaneously pumped from
reagent reservoir. Hybridization was then performed at 50 °C for an additional 10
min. Immediately following the first hybridization, a second hybridization was
performed with the mutant reporter probes mix (0.125 μM of Cyp2C9*2 and
VKORC-1, 0.5 μM of Cyp2C9*3) to which another aliquot of the same denatured
amplified target was pumped into microarray chamber with hybridization buffer
exactly as described above. After both hybridizations were completed, the
microarray chambers were washed with 100 μl of Buffer B (75 mM NaCl, 5 mM
NaH2PO4, 0.5 mM EDTA and 0.1% SDS) at 50 °C for 5 min, followed by a second
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wash carried out for 30 s. After these washes, the microarray filters were processed
for color development by adding HRP and TMB exactly as described above for the
two step hybridization process. All of the custom reporter probes used for the SNP
assay were designed with locked nucleic acids (Table 2) to facilitate higher
stringency melting temperatures and were purchased from Exiqon (Woburn, MA).
3. Results
The use of a universal microarray provides a powerful means to easily and rapidly
detect single or multiplex PCR amplicons of interest. In order to allow an end user
to functionalize the disposable microfluidic cartridge, we utilized 16mer
“universal” probes (Table 1) that were first immobilized onto nylon membranes
to serve as the anchors to which specific, user-defined, “reporter probes” could
subsequently be hybridized. Once the reporter probes were in position via
hybridization, sequences at their 5′ end could be used to hybridize to the PCR
amplicons (Fig. 2). A total of twenty different 16mer universal probes were
evaluated in this study (Table 1).
In order to optimize the hybridization steps on the microfluidic cartridge, we first
evaluated multiple methods using standard “bench top” methods (data not shown).
During the bench top studies, we determined that, depending upon the types of
amplicons being detected, one of two different hybridization methods could be
used to detect the targets of interest. A “two-step” hybridization process was
developed whereby the user-defined reporter probes were first hybridized to the
filter-bound universal probes, followed by hybridization of the PCR amplicons to
the reporter probes. This approach was optimum for the detection of singleplex and
multiplex amplicons resulting from PCR amplification of defined DNA sequences.
For the detection of single nucleotide polymorphisms, however, a “sequenced
Table 2. Six different reporter probes were designed to detect the wildtype (WT) and mutant (Mut) alleles
of single nucleotide polymorphisms (SNP) defined by CYP2C9*2, CYP2C9*3 and VKORC1 loci. The 5′
termini of the reporter probes (shown in red) contain locked nucleic acid sequences (underlined) while the 3′
ends (shown in black) contain sequences complementary to the universal probes.
Probe ID Number Target SNP Reporter Probe Sequence (5′ → 3′)
1 CYP2C9*2_WT TGAGGA+C+C+GTGTTCA CGATGCTGAGGTCGCA
2 CYP2C9*2_Mut T+GA+AC+AC+AG+TC+CT+CA CGATGGTCAGGTGCTG
3 CYP2C9*3_WT A+GG+TC+AA+TG+TA+TC+TC CGATCGCAAGGTGGTC
4 CYP2C9*3_Mut G+AGA+TA+CCT+TGA+CCTT AGGTGCTGTACCCGCA
7 VKORC-1_WT CATCGA+C+C+CTTGGAC TACCGCTGCGATCGCA
6 VKORC1_Mut GT+CCA+AGA+GT+CGA+TGA AGGTCGCATACCGGTC
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hybridization” process provided better results. Since the wild type and mutant
alleles were detected by reporter probes directed against opposite strands of the
same target region and they differed at only a single nucleotide at the site of the
SNP, allowing them to simultaneously flow over the filter-bound universal probes
resulted in the reporter probes hybridizing to each other and thus reducing the
overall signal intensity on the microarray. Therefore, to overcome this, the wild
type reporter probes were allowed to hybridize to the filter-bound universal probes
and then the denatured amplicons flowed over the DNA array. Then, immediately
following this and without any intervening washing steps, the mutant reporter
probes were flowed over the same array and allowed to hybridize to another set of
universal probes on the array. After this hybridization step was completed, another
aliquot of the same denatured amplicons was flowed over the array and hybridized
to the reporter probes. Detection was then achieved by the introduction of
streptavidinylated horse radish peroxidase and TMB substrate.
To demonstrate the ability to detect specific PCR amplicons from targets of
interest, we first designed probes against three separate sexually transmitted
infection (STI) agents, N. gonorroheae (NG), C. trachomatis (CT) and T. vaginalis
(TV). A total of nine individual reporter probes complementary to the 3′ termini of
the anchored universal probes were designed. Two were designed to detect NG
amplicons, four were designed to detect CT amplicons, and three were designed to
detect TV amplicons. Two hundred microliters of individual or combined cultures
of the three STIs were introduced at 1000 cells/ml to the sample reservoir of the
cartridge and automatically processed through the entire sample preparation, PCR
amplification and detection. While the samples were being prepared on the
cartridge, the reporter probes were simultaneously being hybridized to the
universal probes on the universal DNA array. Using the two step hybridization
method, detection of either singly amplified or multiplex amplified targets was
easily distinguished on the DNA array (Fig. 3A). In a parallel study, the limit of
detection for STI microbes was determined by introducing 200 μl of culture
samples at 25, 50, and 75 copies/ml in phosphate buffer saline either individually
or in combination. While the singleplex assay results yielded consistent detection
limits of 25 copies/ml, inconsistency was observed for concentrations below 25
copies/ml (data not shown). Therefore, the limit of detection on the fully automated
cartridge is 25 cells/ml (Fig. 3B).
To investigate the ability to detect upwards of 20 individual targets, we employed
synthetic biotinylated nucleotide sequences to mimic PCR amplicons. Twenty
synthetic targets, ranging from 18 to 25 nucleotides long, were processed exactly
as described for cell cultured targets. To mimic our standard approach, we
designed 20 different “reporter” probes that were first allowed to hybridize to the
20 immobilized “universal” probes, followed by introduction of the biotinylated
oligonucleotides that simulated authentic amplicons. As noted (Fig. 4A, B), all 20
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[(Fig._3)TD$FIG]
Fig. 3. (A) Image of microarray showing hybridization of target amplicons generated from DNA
automatically isolated and PCR amplified from Chlamydia trachomatis (CT), Neisseria gonorrhoeae
(NG) and Trichomonas vaginalis (TV). The sample preparation and PCR amplification was automatically
performed using the cartridge by adding 200 μl of cultured targets (1 × 103copies/ml) to the sample
reservoir either individually or all three mixed together. The PCR amplicons were detected using the two
step hybridization method described in Materials and Methods. Each universal probe was immobilized at
two concentrations (20 μM, 2 μM as described in Materials and Methods). (B) To estimate the limit of
detection, the target microorganisms were diluted to 25, 50 and 75 copies per ml and 200 μl of the
specimens added to the cartridge either individually or all three combined. The location and concentration
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targets, consisting of 19HPV subtypes and 1 STI target, were easily detectable and
distinguishable.
Switching our attention to the detection of single nucleotide polymorphisms
(SNPs), we first evaluated various approaches using bench top experiments (data
not shown). Previous work by our group demonstrated that locked nucleic acid
(LNA) reporter probes provided specific detection of SNPs in a standard array
assay in which the various reporter probes were directly immobilized on the
membrane [26]. Although the previous work demonstrated excellent correlation
between the automated cartridge assay and Sanger sequencing results, that
approach required that the reporter probes complementary to the targets had to first
be immobilized on the membrane prior to the initiation of the assay. In the current
universal array format, only universal probes were immobilized, thus allowing any
user to introduce their own specific reporter probes to detect SNP targets of
interest. Since the LNA reporter probes have increased Tm's as compared to
corresponding reporter probes designed without locked nucleotides, the detection
of the SNPs in the universal array required a different hybridization buffer and
temperatures to facilitate detection of the SNP mutations. The sequential
hybridization process described in Materials and Methods was used to perform
the SNP detection. Our preliminary bench top method evaluations demonstrated
that, in contrast to the two step hybridization methods used to detect the STI
targets, higher salt concentrations and more stringent washes were necessary for
the sequenced hybridization method to successfully detect the SNPs. The cartridge
assay was first optimized using an in-house panel of samples of known genotype
that included homozygous, heterozygous and mutant alleles for CYP29C*2,
CYP29C*3 and VKORC-1 (Fig. 5A). Genomic DNA (1 × 103copies/μl) was
amplified from these samples using bench top manual methods. Due to differing
PCR conditions required for optimum amplification [26], the CYP2C9 targets (*2
and *3) were amplified in one PCR reaction and the VKORC-1 target in a separate
PCR reaction. At the completion of the reactions, however, the amplicons from the
two PCR reactions were pooled prior to hybridization. The amplicons were verified
on agarose gel (Fig. 5A) and the sequenced hybridization carried out using manual
methods (Fig. 5B). The results confirmed the known genotypes of the SNP panel
samples. The same denatured amplicons were then applied to the universal array
and the sequenced hybridization method also yielded correct results (Fig. 5C).
Once we were certain that the sequenced hybridization approach could detect the
correct SNPs in the panel samples, we then collected fresh buccal swabs from
volunteers that had previously been screened by bidirectional Sanger sequencing
for genotypes at the CYP2C9 and VKORC-1 loci. A total of 19 specimens and 2
of the various STI target probes as well as the Spotting Controls (SC) on the DNA array are shown in the
filter key.
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[(Fig._4)TD$FIG]
Fig. 4. (A) Bench top analysis of 20 different surrogate targets biotinylated nucleotide sequences
corresponding to the L-1 region of various HPV subtypes and Chlamydia trachomatis (CT) was
performed by allowing the various reporter probes to flow over the universal DNA array and after
hybridization with the immobilized universal probes, the biotinylated surrogate sequences flowed over
the array and then subsequently detected by incubation with horse radish peroxidase and tetramethyl
benzidine as described in Materials and Methods. The biotinylated target sequences were introduced
either individually or combined together. (B) The same approach that was optimized on the benchtop
was automatically performed in the cartridge under the software control of the Encompass Optimum
workstation. The location of the various probes and spotting controls (SC) are shown in the filter key.
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negative (i.e., no target DNA provided) were analyzed in a blind manner (Fig. 6).
All sample preparation, PCR amplification and detection on the universal
microarray were automatically performed using the workstation with the results
correlating perfectly with the bidirectional Sanger sequencing results.
[(Fig._5)TD$FIG]
Fig. 5. DNA obtained from four samples of known genotype at the CYP2C9*2, CYP2C9*3, and
VKORC1 loci (inset, as determined by Sanger Sequencing) were PCR amplified and run on an agarose
gel (A) to confirm amplification. Then, using bench top methods, the amplicons were analyzed with the
Universal DNA array using the sequenced hybridization method described in Materials and Methods.
The filter key for the Universal DNA array is shown. (B) Universal DNA array results obtained when
amplicons generated in (A) were analyzed using manual methods on the bench top. (C) PCR amplicons
generated on the bench top were analyzed on the cartridge using the sequenced hybridization method
described in Materials and Methods.
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Once parameters were established to convert existing benchtop assays to the fully
automated platform, we then converted an existing manual, bench top PCR assay
for detection of Mycoplasma genitalium (MG) onto the cartridge. Three different
“reporter” probes (Table 3) were designed that had identical nucleotides at their 5′
ends complementary to the gap target amplicons [30] and different nucleotides at
their 3′ ends complementary to three different “universal” probes (Table 1)
immobilized on the DNA array. Two hundred microliters of thimerosol-inactivated
MG, diluted in PBS at concentrations of 25, 50 and 100 cfu/ml were evaluated in
the cartridge assay under the control of the Encompass Optimum workstation. As
noted (Fig. 7), strong signals were obtained for all three concentrations on the
universal cartridge's arrays.
4. Discussion
Despite the power of nucleic acid assays to provide valuable information in
multiple fields, laboratories seeking to use commercially available, end point
detection of multiplex PCR amplicons in fully automated platforms must work
[(Fig._6)TD$FIG]
Fig. 6. Universal DNA arrays resulting from fully automated analysis of 21 different specimens
obtained from volunteers that had previously been genotyped using bi-directional Sanger Sequencing.
Starting with buccal swabs, all assay steps were automatically performed on the Rheonix CARD®
cartridge under the control of the Encompass Optimum workstation. The location of the probes against
the various wild type and mutant alleles is identical to the filter key shown in Fig. 5.
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Table 3. Three different reporter probes were designed to detect the gap gene
found within M. genitalium. Each probe had identical sequences at its 5′ terminus
(shown in red), corresponding to the complement of the gap amplicon, while the 3′
termini had differing sequences, corresponding to the complements of the
immobilized universal probes.
Universal Probe ID Reporter probe sequence (5′→ 3′)
MG-ID_8 TGTTGTTCCAGAAGCAAATGGCAAACTT-TACCGGTCCGATGCTG
MG-ID_9 TGTTGTTCCAGAAGCAAATGGCAAACTT-TACCCGCACGATGGTC
MG-ID_21 TGTTGTTCCAGAAGCAAATGGCAAACTT-GAC AGG GAA CAG CCG T
[(Fig._7)TD$FIG]
Fig. 7. Universal DNA array results obtained by introducing 200 μl of cultures of Mycoplasma
genitalium (MG) to the cartridge. All steps of the assay, including cell lysis, DNA extraction, DNA
purification, PCR amplification, and detection on the integrated universal DNA array, were
automatically performed on the cartridge under the control of the Encompass Optimum software.
The location of the three probes directed against the MG target is shown in the filter key.
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with the respective manufacturers to assure that the proper detection probes are
integrated into the systems’ DNA arrays. Since many laboratories would benefit
from a system that will allow the individual users to modify the DNA arrays at
will, the approach described herein provides a means to develop, alter and optimize
their own assays in an easy-to-use format. In addition, for those clinical
laboratories seeking to develop LDTs, such a system will allow those laboratories
to remain compliant with the anticipated changes in FDA's enforcement of
regulations pertaining to LDTs [23].
Another advantage of the described system is that since the introduction of the
specific reporter probes can be automatically controlled by the workstation while
the remainder of the assay is underway, no time is lost while the DNA array is
being functionalized using user-defined reporter probes. This has the advantage of
more efficient assay development and added versatility for the end user.
Since the various “universal” probes immobilized on the microfluidic cartridge's
DNA array have a fixed nucleic acid sequence, laboratories seeking to develop
their own assays only need to design the various “reporter” probes required to
hybridize to their own PCR amplicons by designing the 3′ end of the reporter probe
to be complementary to the immobilized universal probe and the 5′ end of the
reporter probe to be complementary to the target sequence. Moreover, the reporter
probes should be designed to assure that they do not anneal to themselves or to
other reporter probes in the system. We have taken care to provide sufficient
variability in the universal probe sequences to facilitate such a design. Since all
hybridizations take place under identical conditions, laboratories should also take
care to assure that the various reporter probes and PCR amplicons will favorably
anneal to their respective complements under these identical conditions.
Depending upon the design of the detection scheme, various hybridization
conditions can be implemented. As described above, detection of single or multiple
infectious disease targets can be accomplished by use of a “two step” hybridization
process whereby the reporter probes are first allowed to hybridize to the
immobilized universal probes, followed by a second hybridization step of the PCR
amplicons with the reporter probes now available. In the case of SNP detection,
however, we found it necessary to employ an equally effective, but alternate
“sequenced hybridization” whereby reporter probes, differing by one nucleotide,
were designed against the opposing strands of the amplicons. One reporter probe
was directed against the wild type allele while the other reporter probe designed to
detect the mutant allele was directed against the complementary strand. Since those
two reporter probes would be expected to hybridize to each other if employed
simultaneously, we found that effective detection of SNPs could be achieved by
first delivering the wild type reporter probes and allowing the PCR amplicons to
hybridize, followed by the delivery of the mutant allele reporter probes and
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hybridization with a second aliquot of the same PCR amplicons. This approach
allowed the detection and distinction of the various wild type and mutant alleles
while avoiding the potential pitfall of self-annealing of the various reporter probe
combinations.
To demonstrate the ease of transferring an existing “bench top” assay to the
automated system, we were able to successfully detect Mycoplasma genitalium
using assay parameters developed by another laboratory [30]. The ability to
automatically process untreated specimens through cell lysis, DNA purification
and PCR amplification demonstrates proof of principal and provides a convenient
method to streamline existing assays or assays under development by laboratories
developing their own user-defined assays.
Taken together, the proposed system will provide the convenience and ease-of-use
for laboratories to develop their own fully automated molecular assays. A further
advantage of the system when used in clinical settings is it will provide a means for
clinical laboratories to develop their own user defined assays in a manner that will
allow the labs to remain compliant with anticipated changes in FDA's oversight of
LDTs.
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